Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD
07 sept. 2018 07h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced an expanded Immuno-Oncology Gene Expression Workflow to...
Fluidigm to Participate at Upcoming Investor Events in September
05 sept. 2018 18h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
Fluidigm Announces Second Quarter 2018 Financial Results
02 août 2018 16h05 HE
|
Fluidigm Corporation
Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE...
Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
05 juil. 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
Fluidigm to Participate in Upcoming Investor Events
09 mai 2018 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research
13 avr. 2018 16h10 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Maxpar® Human Immune Monitoring Panel Kit for comprehensive...
Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis
24 oct. 2017 08h10 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a distribution agreement with the University of Zurich to...
European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
04 mai 2017 16h10 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement...
Fluidigm Announces First Quarter Financial Results
04 mai 2017 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2017. Total revenue...
Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
27 mars 2017 16h05 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of...